JUL 29, 2020 3:25 AM PDT

Regulating Apoptosis in Prostate Cancer

WRITTEN BY: Jasper Cantrell

Cancer treatments tend to work in one of a few ways. They can target the immune system, prevent cancer proliferation and metastasis, or induce a cell death pathway. Any of these alone can work against cancer, and some even work better in combination.

A team from the Virginia Common Wealth University wanted to investigate how a new finding in the FOXO1 apoptosis pathway, a cell death pathway, would affect prostate cancer. The FOXO proteins are a family of transcription factors responsible for regulating the expression of certain genes. FOXO1, in particular, controls several pro-apoptosis genes.

This new study built off of previous work that had identified an essential cell cycle regulator, PLK1, as a regulator of FOXO1. PLK1 phosphorylates FOXO1 and prevents its transportation into the nucleus.  Without FOXO1 in the nucleus, the cells apoptotic pathways were silenced. It could even cause increased cancer growth.

The team wanted to see if these findings they saw before were the same in prostate cancer cells. They used FOXO1 mutants that mimicked the phosphorylated and unphosphorylated states to investigate. Like in their previous work, the phosphorylated mimic prevented expression FOXO1 pro-apoptotic genes, and the unphosphorylated mimic correctly localized to the nucleus.

They then wanted to test if they could inhibit PLK1 and prevent the phosphorylation of FOXO1. They used a PLK1 inhibitor in prostate cancer cells and found that it increased FOXO1 in the nucleus, and even induced FOXO1 apoptotic pathways. All signs of a potential anti-cancer drug.

The team then wanted to investigate if the PLK1 inhibitor might be able to work in combination with another anti-cancer drug, nocodazole. Both drugs caused adverse side effects in clinical trials, but together the team hoped they could reduce the dosage and still elicit a strong anti-cancer effect. 

Using prostate cancer cells, they indeed saw a stronger anti-cancer effect with the combination treatment compared to either alone. They even saw signs that the combination did not elicit any harmful side effects when tested in healthy prostate cells.

This study identifies PLK1 inhibitors as potential anti-cancer drugs for prostate cancer. In combination with another compound, nocodazole, it could elicit even stronger anti-cancer activities with no apparent side effects.

The team concluded, “These findings shed light on a novel approach to reactivate apoptotic pathways in advanced PCa and support targeting PLK1-FOXO1 pathways as a novel therapeutic approach for treating advanced PCa.”

Sources: Nature Scientific Reports, Walter Jahn

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
APR 13, 2021
Cancer
New efforts to predict which patients will suffer from side effects from immunotherapy
APR 13, 2021
New efforts to predict which patients will suffer from side effects from immunotherapy
The findings from a study published in the Journal for ImmunoTherapy of Cancer give medical professionals a way to predi ...
MAY 19, 2021
Health & Medicine
Who Ages Better, Men or Women?
MAY 19, 2021
Who Ages Better, Men or Women?
The answer depends on what's considered more important – quantity or quality of years?  Previous studies ...
JUN 01, 2021
Cancer
No level of secondhand smoke is safe for pregnant women
JUN 01, 2021
No level of secondhand smoke is safe for pregnant women
A study published recently in Environmental Health Perspectives concludes that no amount of exposure to secondhand smoke ...
JUN 10, 2021
Cell & Molecular Biology
Does Lithium Prevent Colon Cancer?
JUN 10, 2021
Does Lithium Prevent Colon Cancer?
Researchers found that a drug used in the treatment of mental illness can promote the fitness of healthy gut stem cells, ...
JUN 16, 2021
Cell & Molecular Biology
A Potential Way to Prevent Metastatic Cancer
JUN 16, 2021
A Potential Way to Prevent Metastatic Cancer
Metastatic cancer is the deadliest, and it can happen years after cancer has been treated to the point of remission. Met ...
JUL 26, 2021
Genetics & Genomics
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
JUL 26, 2021
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
Many types of cells have to be replenished continuously throughout our lives, and the genome in the nucleus of those cel ...
Loading Comments...